Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1527503-11-2

Post Buying Request

1527503-11-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1527503-11-2 Usage

Description

5'-Methoxy-6'-[3-(1-pyrrolidinyl)propoxy]spiro[cyclobutane-1,3'-[3H]indol]-2'-amine is a complex organic compound with a unique molecular structure. It is characterized by its spiro-linked cyclobutane and indole rings, along with a methoxy and pyrrolidinylpropoxy functional groups. 5'-Methoxy-6'-[3-(1-pyrrolidinyl)propoxy]spiro[cyclobutane-1,3'-[3H]indol]-2'-amine holds potential for various applications due to its specific structural features and interactions with biological targets.

Uses

Used in Pharmaceutical Industry:
5'-Methoxy-6'-[3-(1-pyrrolidinyl)propoxy]spiro[cyclobutane-1,3'-[3H]indol]-2'-amine is used as a potent peptide-competitive inhibitor for the lysine methyltransferase G9a. It exhibits a high degree of selectivity (1000 fold) over other methyl transferases, making it a valuable compound for the development of targeted therapies in the treatment of various diseases.
Used in Epigenetic Research:
In the field of epigenetics, this compound is utilized as a research tool to study the role of G9a in gene regulation and its implications in disease pathology. By inhibiting G9a, researchers can gain insights into the epigenetic mechanisms that underlie various biological processes and disorders.
Used in Drug Development:
5'-Methoxy-6'-[3-(1-pyrrolidinyl)propoxy]spiro[cyclobutane-1,3'-[3H]indol]-2'-amine serves as a lead compound in the development of new drugs targeting G9a-mediated processes. Its high selectivity and potency make it an attractive candidate for further optimization and refinement to create more effective and safer therapeutic agents.

Biochem/physiol Actions

A-366 is an SGC chemical probe for G9a/GLP, developed in collaboration with Abbvie. A-366 is a potent, selective inhibitor of the histone methyltransferase G9a. The IC50 values for G9a inhbition in enzymatic and cell based assays are 3.3 and approximately 3 μM, respectively. A-366 has little or no detectable activity against a panel of 21 other methyltransferases. For full characterization details, please visit the A-366 probe summary on the Structural Genomics Consortium (SGC) website.To learn about other SGC chemical probes for epigenetic targets, visit sigma.com/sgc

Check Digit Verification of cas no

The CAS Registry Mumber 1527503-11-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,2,7,5,0 and 3 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1527503-11:
(9*1)+(8*5)+(7*2)+(6*7)+(5*5)+(4*0)+(3*3)+(2*1)+(1*1)=142
142 % 10 = 2
So 1527503-11-2 is a valid CAS Registry Number.

1527503-11-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (SML1410)  A-366  ≥98% (HPLC)

  • 1527503-11-2

  • SML1410-5MG

  • 983.97CNY

  • Detail
  • Sigma

  • (SML1410)  A-366  ≥98% (HPLC)

  • 1527503-11-2

  • SML1410-25MG

  • 3,970.98CNY

  • Detail

1527503-11-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name A-366

1.2 Other means of identification

Product number -
Other names A-336

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1527503-11-2 SDS

1527503-11-2Downstream Products

1527503-11-2Relevant articles and documents

INHIBITORS OF HISTONE METHYLTRANSFERASE G9a

-

Paragraph 0208, (2015/12/23)

Described herein are compounds, pharmaceutical compositions and methods for treating cancer, inflammation, or autoimmune disease in a subject, or for inhibiting histone methyltransferase G9a.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1527503-11-2